Search research articles
Contact Us
Filters
Showing results (221-230 of 286) with videos related to
Page
of 29
Sort By:
BMJ Open Gastroenterology
|
January 8, 2025
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis
Séverine Vermeire, David T Rubin, Laurent Peyrin-Biroulet, et al.
Inflammatory Bowel Diseases
|
September 7, 2006
Challenges in pediatric inflammatory bowel disease
Athos Bousvaros, Francisco Sylvester, Subra Kugathasan, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 27, 2007
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America
, , Athos Bousvaros, et al.
Inflammatory Bowel Diseases
|
May 20, 2022
High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course
Stephanie L Gold, Loren G Rabinowitz, Laura Manning, et al.
Journal of Crohn'S & Colitis
|
May 18, 2025
Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel disease
Arno R Bourgonje, Susanne Ibing, Alexandra E Livanos, et al.
The American Journal of Gastroenterology
|
May 7, 2019
Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease
Jing Wu, David M Lubman, Subra Kugathasan, et al.
Journal of Crohn'S & Colitis
|
April 13, 2024
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, et al.
Inflammatory Bowel Diseases
|
August 22, 2020
Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States
Benjamin L Cohen, Zane R Gallinger, Christina Ha, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 5, 2025
Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction Treatment
Remo Panaccione, Marc Ferrante, Iris Dotan, et al.
Inflammatory Bowel Diseases
|
October 24, 2024
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
Bruce E Sands, Geert D'Haens, David B Clemow, et al.
Page
of 29
Search research articles
Search
Showing results (221-230 of 286) with videos related to
Sort By:
Page
of 29
BMJ Open Gastroenterology
|
January 8, 2025
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis
Séverine Vermeire, David T Rubin, Laurent Peyrin-Biroulet, et al.
Inflammatory Bowel Diseases
|
September 7, 2006
Challenges in pediatric inflammatory bowel disease
Athos Bousvaros, Francisco Sylvester, Subra Kugathasan, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 27, 2007
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America
, , Athos Bousvaros, et al.
Inflammatory Bowel Diseases
|
May 20, 2022
High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course
Stephanie L Gold, Loren G Rabinowitz, Laura Manning, et al.
Journal of Crohn'S & Colitis
|
May 18, 2025
Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel disease
Arno R Bourgonje, Susanne Ibing, Alexandra E Livanos, et al.
The American Journal of Gastroenterology
|
May 7, 2019
Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease
Jing Wu, David M Lubman, Subra Kugathasan, et al.
Journal of Crohn'S & Colitis
|
April 13, 2024
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, et al.
Inflammatory Bowel Diseases
|
August 22, 2020
Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States
Benjamin L Cohen, Zane R Gallinger, Christina Ha, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 5, 2025
Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction Treatment
Remo Panaccione, Marc Ferrante, Iris Dotan, et al.
Inflammatory Bowel Diseases
|
October 24, 2024
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
Bruce E Sands, Geert D'Haens, David B Clemow, et al.
Page
of 29